BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Three New Members to Join SLAS Board of Directors


12/23/2013 12:30:01 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHICAGO — The Society for Laboratory Automation and Screening (SLAS) announces the addition of three new members to the nine-­-member SLAS Board of Directors. Each will serve a three-­-year term, beginning Jan. 1, 2014.

Alastair Binnie, Bristol-­-Myers Squibb, Lawrenceville, NJ (USA)

Alastair Binnie is an executive leader with over 15 years of experience leading multi-­-disciplinary technology functions in pharmaceutical discovery and exploratory clinical research. In his current role at Bristol-­-Myers Squibb as vice president, Research Informatics and Automation, he leads a diverse organization responsible for a broad technology agenda supporting all research functions at BMS, including planning, delivering and supporting scientific IT platforms, laboratory automation, instrument support services, scientific computing infrastructure and architecture and software engineering.

Richard M. Eglen, Corning Life Sciences, Corning, NY (USA)

Richard Eglen is currently vice president and general manager at Corning Life Sciences. He possesses more than three decades of professional experience in technical and executive leadership roles at both drug discovery and technology discovery organizations. His current responsibilities include setting strategic direction and serving as general manager of Corning Life Sciences.

Michael Snowden, AstraZeneca, Essex, England (UK)

Michael (Mike) Snowden is vice president, Discovery Sciences within Innovative Medicines at AstraZeneca. A biochemist by trade, he possesses more than 25 years’ experience across a wide array of technological and scientific disciplines related to pre-­-clinical drug discovery. Dr. Snowden has an impressive track record of expert matrix management as well as strategic business development.

Binnie, Eglen and Snowden will fill vacancies created by three existing SLAS Board members, whose three-­-year terms of service conclude on Dec. 31, 2013:

• David Dorsett of Bristol-­-Myers Squibb, Princeton, NJ (USA)

• Jeff Paslay, Ph.D., of Paslay Consulting Group, Kirkland, WA (USA)

• Mary Jo Wildey, Ph.D., Merck Research Labs, Kenilworth, NJ (USA)

“SLAS is proud to endorse its new leaders and grateful for the years of service contributed by those completing their terms,” says 2013 SLAS President Jeff Paslay. “These transitions reinforce the stability of our Society’s governance structure, which ensures continued growth and momentum by balancing sound leadership with an annual influx of fresh thoughts and ideas.”

The confirmation process for Binnie, Eglen and Snowden was conducted in accordance with SLAS bylaws, policies, procedures and strategic plan. The process began with an open call for nominations in September and October. The SLAS Nominations Committee carefully considered proposed candidates in October. In November, final recommendations were approved by the SLAS Board of Directors and presented to the SLAS membership for consideration and comment.

For more information visit www.SLAS.org, contact SLAS Global Headquarters at +1.877.990.SLAS (5727) or e-­-mail slas@slas.org.

The Society for Laboratory Automation and Screening (SLAS) is an international community of more than 15,000 individual scientists, engineers, researchers, technologists and others from academic, government and commercial laboratories. The SLAS mission is to be the preeminent global organization providing forums for education and information exchange and to encourage the study of, and improve the practice of laboratory science and technology. For more information, visit www.SLAS.org.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES